Comparison of the sedative and analgesic effects of butorphanol with acepromazine, midazolam, or dexmedetomidine following propofol induction and isoflurane maintenance in canines
Abstract views: 102 / PDF downloads: 88
Keywords:Acepromazine, Analgesia, Dexmedetomidine, Midazolam, Pain Score, Sedation
Adequate sedation and excellent depth of analgesia were recorded in all the four groups after induction to the end of surgical procedure, however, significantly higher sedation score and depth of analgesia were observed in group D and significantly lower was observed in group A in comparison to other groups. Butorphanol with acepromazine, midazolam, or dexmedetomidine provides adequate sedation and analgesia in the dogs, before induction with propofol, so it made handling of the animals proper and safe before induction. Dexmedetomidine produces most profound sedation and analgesia followed by midazolam and acepromazine along with butorphanol.
Ahmad R A, Kinjavdekar P, Aithal H P, Pawde A M and Kumar D. 2013. Potential use of dexmedetomidine for different levels of sedation, analgesia and anaesthesia in dogs. Veterinarni Medicina 58(2): 87–95. DOI: https://doi.org/10.17221/6699-VETMED
Bednarski R, Grimm K, Harvey R, Lukasik V M, Penn W S, Sargent B and Spelts K. 2011. AAHA anesthesia guidelines for dogs and cats. Journal of the American Animal Hospital Association 47(6): 377–85. DOI: https://doi.org/10.5326/JAAHA-MS-5846
Bigby S E, Beths T, Bauquier S and Carter J E. 2017. Post- induction apnoea in dogs pre-medicated with acepromazine or dexmedetomidine and anaesthetized with alfaxalone or propofol. Veterinary Anaesthesia and Analgesia 44(5): 1007– 15. DOI: https://doi.org/10.1016/j.vaa.2016.10.004
Bufalari A, Miller S M, Short C E and Giannoni G. 1997. The use of propofol for induction of anaesthesia in dogs pre- medicated with acepromazine, butorphanol and acepromazine- butorphanol. New Zealand Veterinary Journal 45(4): 129–34. DOI: https://doi.org/10.1080/00480169.1997.36012
Canfran S, Bustamante R, González P, Cediel R Re M and de Segura I G. 2016. Comparison of sedation scores and propofol induction doses in dogs after intramuscular administration of dexmedetomidine alone or in combination with methadone, midazolam, or methadone plus midazolam. Veterinary Journal 210: 56–60. DOI: https://doi.org/10.1016/j.tvjl.2016.01.015
Carregaro A B, Ueda G I, Censoni J B, Bisetto S P, Alonso B B and Reginato G M. 2020. Effect of methadone combined with acepromazine or detomidine on sedation and dissociative anesthesia in healthy horses. Journal of Equine Veterinary Science 86: 102908. DOI: https://doi.org/10.1016/j.jevs.2019.102908
Commiskey S, Fan L W, Ho K and Rockhold, R W. 2005. Butorphanol: Effects of a prototypical agonist-antagonist analgesic on κ-opioid receptors, Journal of Pharmacological Sciences 98(2): 109–16. DOI: https://doi.org/10.1254/jphs.CRJ05001X
Correa-Sales C, Rabin B C and Maze M. 1992. A hypnotic response to dexmedetomidine, an alpha-2 agonist, is mediated in the locus coeruleus in rats. Anaesthesiology 76(6): 948–52. DOI: https://doi.org/10.1097/00000542-199206000-00013
Costa G P, Monteiro E R, Marques É J, Beck R C, Carneiro R K, da Costa F V and Valle S F. 2021. Sedative effects of acepromazine in combination with nalbuphine or butorphanol, intramuscularly or intravenously, in healthy cats: A randomized, blinded clinical trial. Journal of Feline Medicine and Surgery 23(6): 540–48. DOI: https://doi.org/10.1177/1098612X20962754
Daabiss M. 2011. American Society of Anaesthesiology : Physical status classification. Indian Journal of Anaethesia 55(2): 111. DOI: https://doi.org/10.4103/0019-5049.79879
Granholm M, McKusick B C, Westerholm F C and Aspegrén J C. 2007. Evaluation of the clinical efficacy and safety of intramuscular and intravenous doses of dexmedetomidine and medetomidine in dogs and their reversal with atipamezole. Veterinary Record 160(26): 891–97. DOI: https://doi.org/10.1136/vr.160.26.891
Honkavaara J M, Raekallio M R, Kuusela E K, Hyvärinen E A and Vainio O M. 2008. The effects of L-659,066, a peripheral alpha-2 adrenoceptor antagonist, on dexmedetomidine- induced sedation and bradycardia in dogs. Veterinary Anaesthesia and Analgesia 35(5): 409–13. DOI: https://doi.org/10.1111/j.1467-2995.2008.00403.x
Hopkins A, Giuffrida M and Larenza M P. 2014. Midazolam, as a co induction agent, has propofol sparing effects but also decreases systolic blood pressure in healthy dogs. Veterinary Anaesthesia and Analgesia 41(1): 64–72. DOI: https://doi.org/10.1111/vaa.12088
Kumar R, Aakanksha A K, Verma N K, Saxena A C and Hoque M. 2020. Systemic effects and clinical application of dexmedetomidine. The Pharma Innovation Journal 9(11): 241–46. DOI: https://doi.org/10.22271/tpi.2020.v9.i11d.5344
Kojima K, Nishimura R, Mutoh T, Takao K, Matsunaga S, Mochizuki M and Sasaki N. 1999. Comparison of sedative effects of medetomidine midazolam, acepromazine, butorphanol and midazolam butorphanol in dogs. Journal of Veterinary Medicine Series A 46(3): 141–48. DOI: https://doi.org/10.1046/j.1439-0442.1999.00194.x
Monteiro E R, Junior A R, Assis H M Q, Campagnol D and Quitzan J G. 2009. Comparative study on the sedative effects of morphine, methadone, butorphanol or tramadol in combination with acepromazine in dogs. Veterinary Anaesthesia and Analgesia 36(1): 25–33. DOI: https://doi.org/10.1111/j.1467-2995.2008.00424.x
Murrell J C. 2007. Choice of premedicants in cats and dogs. In Practice 29(2): 100–06. DOI: https://doi.org/10.1136/inpract.29.2.100
Murrell J C and Hellebrekers L J. 2005. Medetomidine and dexmedetomidine: Areview of cardiovascular effects and antinociceptive properties in the dog. Veterinary Anaesthesia and Analgesia 32(3): 117–27. DOI: https://doi.org/10.1111/j.1467-2995.2005.00233.x
National Office of Animal Health. 2010. Torbugesic 1% w/v Solution for Injection: Dosage and administration.
Pypendop B H, Honkavaara J and Ilkiw J E. 2017. Cardiovascular effects of dexme- detomidine, with or without MK-467, following intravenous administration in cats. Veterinary Anaesthesia and Analgesia 44(1): 52–62. DOI: https://doi.org/10.1111/vaa.12397
Sano T, Nishimura R, Mochizuki M and Sasaki N. 2003. Effects of midazolam- butorphanol, acepromazine-butorphanol and medetomidine on an induction dose of propofol and their compatibility in dogs. Journal of Veterinary Medical Science 65(10): 1141–43. DOI: https://doi.org/10.1292/jvms.65.1141
Shirasaka T, Hiroshi K and Mayumi T. 2007. Activation of a G protein–coupled inwardly rectifying K+ current and suppression of I h contribute to dexmedetomidine- induced inhibition of rat hypothalamic paraventricular nucleus neurons. The Journal of the American Society of Anesthesiologists 107(4): 605–15. DOI: https://doi.org/10.1097/01.anes.0000281916.65365.4e
Tranquilli W J, Thurmon J C and Grimm K A. 2013. Lumb and Jones’ Veterinary Anesthesia and Analgesia. John Wiley and Sons.
Wagner M C, Hecker K G and Pang D S. 2017. Sedation levels in dogs: A validation study. BMC Veterinary Research 13(1): 1–8. DOI: https://doi.org/10.1186/s12917-017-1027-2
Wang J, Sun P and Liang P. 2020. Neuropsychopharmacological effects of midazolam on the human brain. Brain Informatics 7(1): 1–12. DOI: https://doi.org/10.1186/s40708-020-00116-y
How to Cite
The copyright of the articles published in The Indian Journal of Animal Sciences is vested with the Indian Council of Agricultural Research, which reserves the right to enter into any agreement with any organization in India or abroad, for reprography, photocopying, storage and dissemination of information. The Council has no objection to using the material, provided the information is not being utilized for commercial purposes and wherever the information is being used, proper credit is given to ICAR.